Table 2 The relationship between SPP1 expression level and different clinical and pathological features
Characteristics | Total | Low-SPP1* | High-SPP1 | P | |||
|---|---|---|---|---|---|---|---|
NO. | % | NO. | % | NO. | % | ||
Gender | 0.156 | ||||||
Men | 43 | 51 | 29 | 56 | 14 | 41.2 | |
Women | 42 | 49 | 22 | 44 | 20 | 58.8 | |
Age | 0.854 | ||||||
≤60 | 31 | 36.5 | 19 | 37.3 | 12 | 35.3 | |
>60 | 54 | 63.5 | 32 | 62.7 | 22 | 64.7 | |
Smoking History | 0.318 | ||||||
<20 | 52 | 61.2 | 29 | 56.9 | 23 | 67.6 | |
≥20 | 33 | 38.8 | 22 | 43.1 | 11 | 32.4 | |
Histology | 0.072 | ||||||
Adenocarcinoma | 67 | 78.8 | 39 | 76.5 | 28 | 82.4 | |
Squamous | 13 | 15.3 | 11 | 21.6 | 2 | 5.9 | |
Adenosquamous | 1 | 1.2 | 0 | 0 | 1 | 2.9 | |
Unknown | 4 | 4.7 | 1 | 1.9 | 3 | 8.8 | |
Lymphatic Metastasis | 0.164 | ||||||
≤N1 | 14 | 16.5 | 6 | 11.8 | 8 | 23.5 | |
>N1 | 70 | 82.4 | 44 | 86.3 | 26 | 76.5 | |
Unknown | 1 | 1.1 | 1 | 1.9 | 0 | 0 | |
Metastasis organ | 0.03 | ||||||
0 | 27 | 34.4 | 21 | 42.4 | 6 | 21.6 | |
≥1 | 53 | 57.3 | 28 | 50.8 | 25 | 67.6 | |
Unknown | 5 | 8.3 | 2 | 6.8 | 3 | 10.8 | |